It is well known that the number of peritoneal macrophages is increased in
patients with pelvic endometriosis. We measured the concentration of monocy
te chemoattractant protein-1 (MCP-1) using an enzyme-linked immunosorbent a
ssay (ELISA) in the peritoneal fluid of women with and without endometriosi
s. The expression of MCP-1 in pelvic endometriotic lesions obtained from th
e peritoneum was also examined using immunohistochemistry and nonradioactiv
e in situ hybridization. The mean concentration of MCP-1 in the peritoneal
fluid was significantly higher in the patients with endometriosis (P<0.05).
The most significant elevation, compared with non-endometriosis patients,
was found in stage I of the disease (P<0.05). However, no statistically sig
nificant difference was found among endometriosis stages I, II, III, and IV
. Immunohistochemical staining revealed that MCP-1-positive cells were loca
lized in the glandular epithelium of the endometriotic lesions and in the s
tromal macrophages distributed in those lesions, but normal peritoneal cell
s were negative. The in situ hybridization method demonstrated expression o
f MCP-1 mRNA on the endometriotic glandular epithelium and stromal macropha
ges. These findings suggest that MCP-1 may be involved in the histogenesis
and early development of peritoneal endometriosis.